GLUE·61225M102·US·equity·Healthcare - Biotechnology-Activist
GLUE (MONTE ROSA THERAPEUTICS INC) is held by 103 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($92.7M), BAKER BROS. ADVISORS LP ($71.5M), STATE STREET CORP ($55.2M). Net institutional sentiment: Bullish.
See how GLUE's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer